The treatment of amblyopia

Strabismus
Jonathan M HolmesMichael P Clarke

Abstract

Recent studies suggest that children with amblyopia associated with anisometropia, strabismus, or both should be treated initially with best refractive correction until visual acuity is stable. This may take several months, and a proportion of children will achieve equal visual acuity with glasses alone. For residual anisometropic and strabismic amblyopia, the initial choice of patching or atropine should involve the parent and the child. The dose of prescribed patching or atropine may initially be quite modest, such as 2 hours of patching a day or twice weekly atropine. Treatment should be offered to children until at least 12 years of age and possibly to teenagers. Ongoing studies are addressing the role of undertaking near activities while patched and the role of atropine for severe amblyopia and for older amblyopic children. Future studies are needed to investigate the best treatment strategies for residual amblyopia, whether weaning treatment is needed at the end of a course, and how compliance can be enhanced.

References

Jan 26, 2000·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·R W Beck
Aug 17, 2001·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·S R ColeUNKNOWN Pediatric Eye Disease Investigator Group
Sep 27, 2001·Archives of Ophthalmology·J M HolmesUNKNOWN Pediatric Eye Disease Investigator Group
Mar 15, 2002·Archives of Ophthalmology·UNKNOWN Pediatric Eye Disease Investigator Group.
Aug 7, 2002·Ophthalmic & Physiological Optics : the Journal of the British College of Ophthalmic Opticians (Optometrists)·Merrick J MoseleyAlistair Fielder
May 14, 2003·Archives of Ophthalmology·Michael X RepkaUNKNOWN Pediatric Eye Disease Investigator Group
Oct 1, 2003·American Journal of Ophthalmology·UNKNOWN Pediatric Eye Disease Investigator Group
Nov 5, 2003·Ophthalmology·Jonathan M HolmesUNKNOWN Pediatric Eye Disease Investigator Group
Nov 12, 2003·Archives of Ophthalmology·Jonathan M HolmesUNKNOWN Pediatric Eye Disease Investigator Group
Aug 25, 2004·Investigative Ophthalmology & Visual Science·Catherine E StewartAlistair R Fielder
Nov 4, 2004·Ophthalmology·Michael X RepkaUNKNOWN Pediatric Eye Disease Investigator Group
Nov 19, 2004·The British Journal of Ophthalmology·C E StewartUNKNOWN MOTAS Cooperative
Feb 16, 2005·Archives of Ophthalmology·Michael X RepkaUNKNOWN Pediatric Eye Disease Investigator Group
Mar 26, 2005·Investigative Ophthalmology & Visual Science·Musarat AwanIrene Gottlob
Apr 13, 2005·Archives of Ophthalmology·Mitchell M ScheimanUNKNOWN Pediatric Eye Disease Investigator Group
Apr 20, 2005·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Jonathan M HolmesUNKNOWN Pediatric Eye Disease Investigator Group
Aug 27, 2005·Investigative Ophthalmology & Visual Science·Catherine E StewartMerrick J Moseley

❮ Previous
Next ❯

Citations

Dec 4, 2012·Progress in Retinal and Eye Research·Eileen E Birch
Jun 3, 2009·Developmental Disabilities Research Reviews·Michael V Johnston
Mar 15, 2012·Developmental Psychobiology·Benjamin ThompsonRobert F Hess
Apr 28, 2010·The Laryngoscope·B Robert PetersManuel Manrique
Jun 24, 2015·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Claudia Kuhli-HattenbachMaria Fronius
Apr 29, 2015·Ophthalmology·Creig Hoyt
Oct 22, 2013·Seminars in Ophthalmology·Behzad MansouriDean M Cestari
Aug 30, 2011·Strabismus·Merrick J Moseley, Catherine E Stewart
Aug 30, 2011·Strabismus·Catherine E StewartAlistair R Fielder
Apr 25, 2015·Trials·Merrick J MoseleyUNKNOWN RODS (Randomized Occlusion Dosing Strategies) Study Cooperative
Jun 19, 2013·Progress in Retinal and Eye Research·Brendan T BarrettT Rowan Candy
Jul 2, 2009·Korean Journal of Ophthalmology : KJO·Satendra Singh, Shikha Gautam
Oct 26, 2013·Japanese Journal of Ophthalmology·Fumiko KishimotoHiroshi Ohtsuki
Mar 23, 2011·International Ophthalmology·Evgenia Kanonidou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Ophthalmology
Pediatric Eye Disease Investigator GroupDonny W Suh
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus
Michael X RepkaPediatric Eye Disease Investigator Group
© 2021 Meta ULC. All rights reserved